For many stakeholders within the healthcare industry, the world of open research is an exciting yet occasionally confusing one. At the start of this year, key industry players from across the pharma industry met in Oxford for a roundtable discussion hosted by Wiley on ‘How the pharma–publisher relationship should evolve in the new world of … Continue reading Guest post: The open road
New research in overall support of the Evidence [Aid]
Humanitarians working in crisis zones need real-time access to evidence. A recent study from McMaster University in Canada explored the effectiveness of Evidence Aid’s resource collections on critical decision-making
CBMRT US Biomedical Transparency Summit newsletter
The Center for Biomedical Research Transparency (CBMRT) hosts a free 5-year Biomedical Transparency Summit (BMTS) series in the US and Europe. The goal of BMTS is to promote discussion and collaboration on transparency across the global biomedical research ecosystem
Linking Evidence to Aid researchers in tackling the 2019 novel coronavirus outbreak
As the collection of literature and resources on the 2019 novel coronavirus outbreak increases, Evidence Aid is working to ensure links to the latest research are made discoverable
Combatting the next outbreak: why open access matters
As the Open Pharma position statement reaches over 100 endorsements, we share why open access is important for public health and hear why publishing house Frontiers has endorsed the position statement.
Guest post: Some of the open science challenges faced by authors in Japan
Scientific and medical publishing is becoming more open around the world, including in Japan, where open access and open science are gaining traction.
The evolving role of medical publication professionals in improving the accessibility and discoverability of scientific research
Open Pharma Members, Supporters and key advisers came together to discuss how medical publication professionals can improve the accessibility and discoverability of scientific research.
What does the future look like for medical publications? Insights from ISMPP EU 2020
The 2020 European Meeting of the International Society for Medical Publication Professionals (ISMPP) opened with a question – in one word, “how do you feel about the future of medical publications?” Answers included “exciting”, “evolving” and “digital”.
Reflecting on the release of the Open Pharma position statement on open access
Today, just over two weeks from the launch of the Open Pharma position statement on open access, we reflect on how the statement came about, the benefits it offers to different types of stakeholders and the success it has had so far.
Find out what Open Pharma achieved during Open Access Week 2019
Last week was International Open Access Week covering the topic ‘Open for whom? Equity in open knowledge’. Open Pharma kicked off this year’s Open Access Week with the launch of its position statement on open access at a MedComms Networking event in Oxford on 21 October 2019. The statement calls for publishers to allow authors … Continue reading Find out what Open Pharma achieved during Open Access Week 2019